No Data
No Data
Risks Still Elevated At These Prices As Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE:300006) Shares Dive 36%
Further Weakness as Chongqing Lummy Pharmaceutical (SZSE:300006) Drops 13% This Week, Taking Three-year Losses to 33%
Lummy Pharmaceutical Gets Nod For Alanyl Glutamine Injection's Two Specifications; Shares Up 8%
Optimistic Investors Push Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE:300006) Shares Up 26% But Growth Is Lacking
Laimei Pharmaceutical Obtains Approval for Cefpodoxime Proxetil Suspension
We Think Chongqing Lummy Pharmaceutical's (SZSE:300006) Healthy Earnings Might Be Conservative